CYTL1 and neoplasm: CYTL1 has been reported to inhibit STAT3 phosphorylation, and a decrease in STAT3 phosphorylation expression was accompanied by an increase in anti-angiogenic effects, thereby inhibiting tumor progression [103,104,105].